middl
east
respiratori
syndrom
coronaviru
merscov
novel
viru
emerg
caus
acut
respiratori
distress
syndrom
ard
sever
pneumonialik
symptom
multiorgan
failur
case
fatal
rate
limit
clinic
studi
indic
human
infect
merscov
exhibit
patholog
consist
late
stage
ard
reminisc
diseas
observ
patient
infect
sever
acut
respiratori
syndrom
coronaviru
model
merscovinduc
sever
respiratori
diseas
difficult
achiev
smallanim
model
tradit
use
investig
viral
pathogenesi
mous
hamster
guineapig
ferret
natur
resist
merscov
therefor
use
gene
edit
modifi
mous
genom
encod
two
amino
acid
posit
match
human
sequenc
dipeptidyl
peptidas
receptor
make
mice
suscept
merscov
infect
replic
serial
merscov
passag
engin
mice
use
gener
mouseadapt
viru
replic
effici
within
lung
evok
symptom
indic
sever
ard
includ
decreas
surviv
extrem
weight
loss
decreas
pulmonari
function
pulmonari
haemorrhag
patholog
sign
indic
endstag
lung
diseas
importantli
therapeut
countermeasur
compris
merscov
neutral
antibodi
treatment
merscov
spike
protein
vaccin
protect
engin
mice
merscovinduc
ard
sever
respiratori
ill
caus
middl
east
respiratori
syndrom
coronaviru
merscov
pandem
potenti
humantohuman
respiratori
transmiss
dearth
effect
treatment
necessit
develop
new
merscov
therapi
vaccin
effect
vaccin
therapeut
develop
requir
preclin
anim
model
resembl
pathogenesi
human
merscov
infect
addit
model
includ
measur
mortal
associ
sever
respiratori
diseas
confound
neurolog
complic
due
high
viral
load
brain
exhibit
sustain
highlevel
viru
replic
within
lung
infect
anim
exhibit
lung
patholog
associ
human
acut
respiratori
distress
syndrom
ard
maintain
innat
express
merscov
host
receptor
dipeptidyl
peptidas
prevent
perturb
immunolog
homeostasi
genet
tractabl
studi
host
gene
regul
respons
merscov
vaccin
therapeut
exhibit
reproduc
convent
nonhuman
primat
nhp
model
establish
merscov
rhesu
macaqu
common
marmoset
nhp
instrument
preclin
develop
therapeut
howev
model
costprohibit
initi
screen
larg
number
vaccin
therapeut
candid
challeng
work
routin
pathogenesi
studi
limit
avail
typic
requir
high
viru
challeng
dose
multipl
site
furthermor
two
recent
studi
contradict
initi
studi
nhp
may
complic
use
rhesu
macaqu
common
marmoset
model
routin
vaccin
therapeut
test
merscov
fail
replic
tradit
smallanim
model
mous
hamster
guineapig
ferret
due
inabl
receptorbind
domain
merscov
spike
protein
interact
respect
receptor
addit
act
merscov
receptor
regul
tcell
activ
cytokin
function
transendotheli
migrat
site
inflamm
therefor
overexpress
may
result
immun
dysregul
effect
model
would
therefor
ideal
promot
function
interact
minim
perturb
innat
express
signal
activ
tissu
distribut
classic
strategi
overcom
receptor
incompat
gener
suscept
mice
reli
gener
tissuespecif
transgen
overexpress
approach
drive
express
human
receptor
mous
although
merscov
elicit
respiratori
diseas
overexpress
model
model
exhibit
fatal
central
nervou
system
cn
system
multiorgan
diseas
probabl
due
nonspecif
overexpress
receptor
throughout
anim
complic
studi
merscovinduc
respiratori
pathogenesi
model
studi
use
knowledg
determin
allow
mous
act
function
merscov
receptor
use
cluster
regularli
interspac
short
palindrom
repeat
crisprassoci
gene
genom
edit
technolog
insert
codon
match
human
sequenc
posit
mous
gene
strategi
result
mous
permiss
merscov
infect
maxim
preserv
speciesspecif
interact
network
critic
immun
function
gener
mice
carri
chimaer
mous
molecul
combin
mouseadapt
strain
merscov
allow
us
gener
mous
model
resembl
sever
merscovinduc
respiratori
diseas
without
bystand
neurolog
diseas
parallel
demonstr
model
system
use
develop
test
merscov
vaccin
therapeut
mous
model
merscov
infect
demonstr
previous
introduct
two
amino
acid
match
human
sequenc
posit
receptor
support
merscov
dock
entri
replic
cell
cultur
determin
locat
within
exon
chromosom
fig
supplementari
fig
therefor
use
genom
edit
introduc
determin
receptor
fig
supplementari
tabl
two
line
mice
gener
either
homozyg
heterozyg
chimaer
allel
fig
homozyg
mice
encod
chang
chromosom
therebi
express
chang
fig
heterozyg
mice
encod
chang
one
chromosom
wildtyp
amino
acid
chromosom
therebi
express
mutat
wildtyp
fig
innat
express
level
pattern
lung
kidney
brain
mice
reflect
observ
wildtyp
mice
fig
c
supplementari
fig
central
mainten
glucos
homeostasi
mammal
blood
glucos
level
within
normal
rang
observ
wildtyp
mice
support
hypothesi
biolog
function
alter
mice
supplementari
fig
moreov
basal
tcell
express
tumournecrosi
line
compar
level
observ
wildtyp
mice
supplementari
fig
notwithstand
function
tcell
assess
result
suggest
minim
alter
allel
alter
basal
tcell
activ
statu
overal
express
level
express
pattern
biolog
function
immunolog
profil
compar
wildtyp
mice
follow
sitespecif
modif
allel
mice
support
effici
infect
replic
human
merscov
strain
camel
mer
strain
recombin
viru
deriv
molecular
infecti
clone
icmer
lung
viru
strain
could
replic
wildtyp
mice
retain
origin
murin
allel
fig
parallel
merscov
tissuecultureadapt
variant
deriv
infect
cell
ectop
express
chimaer
receptor
found
encod
three
amino
acid
insert
rmr
fig
lung
histolog
demonstr
nucleocapsid
antigen
fig
strain
shown
readili
detect
lung
infect
mice
immunohistochemistri
infect
lung
exhibit
moder
sign
respiratori
patholog
inflamm
result
demonstr
develop
merscov
model
could
support
high
level
viru
replic
day
postinfect
pi
vivo
adapt
requir
achiev
respiratori
symptom
characterist
merscov
infect
human
recombinantli
deriv
viru
mous
adapt
serial
passag
round
lung
mice
interv
result
strain
infect
mice
via
intranas
rout
result
mortal
genuin
mortal
rather
mice
meet
typic
weight
loss
cutoff
associ
human
euthanasia
criteria
infect
mice
surviv
fig
howev
line
exhibit
weight
loss
day
pi
contrast
mice
wildtyp
mice
exhibit
weight
loss
fig
significantli
higher
level
replic
detect
lung
mice
day
pi
mostli
clear
lung
day
pi
fig
similar
replic
wildtyp
mice
importantli
observ
decreas
surviv
weight
loss
induc
confound
neurolog
complic
brain
infect
plaqu
assay
replicationcompet
viru
pcr
revers
transcript
rtpcr
day
pi
neg
supplementari
fig
moreov
quantit
rtpcr
sampl
demonstr
increas
detect
viral
transcript
infect
lung
compar
similarli
infect
mice
detect
viral
transcript
brain
mice
supplementari
fig
although
mortal
weight
loss
provid
import
measur
merscovinduc
diseas
paramet
directli
assess
impact
viru
replic
respiratori
function
therefor
directli
assess
impact
infect
respiratori
function
mice
measur
respiratori
function
use
unrestrain
plethysmographi
demonstr
previous
respiratori
pathogenesi
mous
model
sever
acut
respiratori
syndrom
sar
influenza
elicit
sever
lung
diseas
quantifi
enhanc
paus
penh
unitless
measur
reflect
airway
obstructionrestrict
due
debri
airway
midtid
expiratori
flow
ef
repres
flow
rate
tidal
volum
expel
singl
breath
infect
led
signific
increas
penh
ef
mice
day
pi
compar
mice
infect
wildtyp
mice
infect
fig
b
demonstr
elicit
sever
respiratori
distress
mice
carri
chimaer
receptor
support
observ
sever
haemorrhag
lung
mice
infect
day
supplementari
fig
inflammatori
infiltr
day
fig
respiratori
patholog
associ
sever
acut
respiratori
distress
includ
hyalin
membran
format
intraalveolar
oedema
perivascular
cuf
sever
inflamm
day
pi
fig
quantit
comparison
lung
patholog
mice
infect
demonstr
induc
signific
level
patholog
commensur
ard
day
pi
supplementari
fig
although
conduct
exhaust
assess
extrapulmonari
tissu
mice
could
detect
viru
replic
brain
even
dose
plaqueform
unit
pfu
day
human
euthanasia
end
point
reach
patholog
observ
model
consist
sever
respiratori
patholog
associ
fatal
ard
publish
case
studi
human
merscov
infect
identif
merscovadapt
mutat
associ
sever
respiratori
diseas
anticip
merscov
genom
would
acquir
mutat
due
immunolog
pressur
andor
enhanc
viru
fit
mous
adapt
two
viral
fig
wherea
clonal
isol
caus
weight
loss
fig
high
level
viru
replic
mice
day
pi
human
euthanasia
end
point
reach
fig
lung
patholog
elicit
resembl
obtain
primari
viru
fig
demonstr
similar
patholog
includ
oedema
hyalin
membran
format
perivascular
cuf
sequenc
entir
genom
reveal
set
uniqu
missens
mutat
acquir
vivo
passag
gene
encod
nonstructur
protein
larg
delet
may
respons
enhanc
diseas
observ
supplementari
fig
sequenc
reveal
differ
may
influenc
capac
viru
elicit
increas
mortal
observ
name
mutat
expand
delet
extend
supplementari
fig
moreov
rapid
amplif
cdna
end
reveal
nucleotid
posit
untransl
region
delet
clone
supplementari
fig
gener
infecti
clone
harbour
mutat
demonstr
diseas
could
reproduc
infecti
dose
pfu
supplementari
fig
decreas
dose
pfu
result
weight
loss
parallel
observ
pfu
howev
pfu
dose
exhibit
slight
decreas
mortal
day
pi
supplementari
fig
although
addit
studi
need
compar
genom
analysi
two
clone
indic
may
signific
role
determin
diseas
outcom
therefor
deriv
viru
combin
mous
line
repres
use
tool
studi
merscov
pathogenesi
assess
therapeut
countermeasur
merscovinduc
ard
human
monoclon
antibodi
protect
merscovelicit
sever
respiratori
diseas
human
monoclon
antibodi
provid
robust
strategi
treatment
newli
emerg
virus
human
human
monoclon
antibodi
target
receptorbind
domain
merscov
spike
protein
effect
nhp
adapt
viru
acquir
receptorbind
domain
mutat
supplementari
fig
reason
protect
mice
challeng
pretreat
mice
h
provid
protect
challeng
fig
b
moreov
treatment
reduc
viral
load
lung
infect
mice
undetect
level
fig
supplementari
fig
protect
loss
respiratori
function
fig
supplementari
fig
pulmonari
haemorrhag
supplementari
fig
sever
patholog
chang
supplementari
fig
contrast
pretreat
isotyp
control
antibodi
provid
protect
effect
therefor
data
convincingli
demonstr
preclin
mous
model
sever
respiratori
diseas
mortal
serv
platform
assess
merscov
therapeut
spike
protein
vaccin
deriv
venezuelan
equin
enceph
viru
replicon
particl
protect
lethal
infect
examin
vaccin
efficaci
model
mice
vaccin
venezuelan
equin
enceph
replicon
particl
vrp
express
merscov
spike
protein
spikevrp
mock
vaccin
vrp
express
green
fluoresc
protein
gfpvrp
boost
week
postprim
challeng
week
postboost
mice
receiv
spikevrp
surviv
exhibit
weight
loss
follow
challeng
compar
gfpvrp
mockvaccin
anim
fig
b
spikevrp
vaccin
significantli
reduc
replic
lung
infect
mice
shown
plaqu
titr
fig
viral
antigen
stain
supplementari
fig
also
protect
sever
respiratori
diseas
assess
measur
penh
fig
ef
supplementari
fig
lung
haemorrhag
supplementari
fig
patholog
indic
sever
acut
respiratori
diseas
supplementari
fig
neutral
prechalleng
serum
spikevrpvaccin
mice
valid
presenc
hightitr
neutral
antibodi
serum
vaccin
mice
supplementari
fig
data
demonstr
spikevrp
vaccin
provok
adapt
immun
respons
capabl
protect
mice
lethal
challeng
merscov
therebi
extend
util
preclin
mous
model
sever
respiratori
diseas
includ
vaccin
evalu
c
viral
lung
titr
determin
day
pi
n
isotyp
controltr
mice
day
pi
n
mice
n
isotyp
controltr
mice
limit
detect
lod
indic
bar
mean
sd
lung
function
assess
penh
day
pi
mice
receiv
n
day
isotyp
control
n
day
n
day
data
mean
sd
student
ttest
use
compar
mice
receiv
receiv
isotyp
control
day
day
pi
p
p
merscov
preclin
mous
model
describ
demonstr
first
time
system
use
genet
edit
nonpermiss
host
receptor
gener
suscept
model
emerg
infecti
pathogen
merscov
mous
model
resembl
sever
often
fatal
respiratori
distress
syndrom
observ
human
prevent
treatment
neutral
monoclon
antibodi
vrpbase
vaccin
direct
merscov
spike
protein
coupl
inabl
elicit
escap
mutant
also
test
nhp
make
excel
candid
downstream
human
studi
howev
exist
nhp
model
reli
quantit
rtpcr
rather
measur
infecti
viru
quantifi
viral
load
model
reproduc
result
sever
respiratori
diseas
mortal
observ
human
mer
patient
therefor
result
model
complement
nhp
studi
directli
demonstr
reduc
level
infecti
merscov
lung
prevent
sever
virusinduc
respiratori
patholog
loss
respiratori
function
mortal
fatal
case
human
merscov
infect
individu
exhibit
sever
respiratori
distress
requir
mechan
ventil
publish
human
autopsi
merscov
fatal
report
histopatholog
includ
diffus
alveolar
damag
denud
bronchiolar
epithelium
hyalin
membran
format
type
ii
pneumocyt
hyperplasia
oedema
furthermor
merscov
antigen
stain
local
viru
pneumocyt
syncyti
cell
infect
type
ii
pneumocyt
lead
cell
death
observ
autopsi
patient
die
sever
respiratori
infect
influenza
viru
sarscov
moreov
pneumocyt
cell
death
propos
caus
decreas
respiratori
function
measur
wholebodi
plethysmographi
mous
model
influenza
commensur
previou
studi
merscov
mous
model
demonstr
widespread
infect
pneumocyt
patholog
consist
diffus
alveolar
damag
sever
respiratori
diseas
corrobor
decreas
pulmonari
function
merscov
model
measur
plethysmographi
may
associ
widespread
infect
possibl
death
pneumocyt
airway
epitheli
cell
therefor
model
system
provid
field
opportun
investig
mechan
lead
merscovinduc
patholog
sever
respiratori
diseas
absenc
cn
complic
merscov
mous
model
use
tradit
method
express
fulllength
human
receptor
facilit
merscov
infect
model
exhibit
infect
replic
lung
follow
intranas
administr
low
viral
dose
pfu
case
result
patholog
indic
pneumonialik
diseas
one
limit
merscov
model
describ
use
high
viral
load
achiev
sever
often
fatal
respiratori
diseas
adapt
may
allow
use
lower
infecti
dose
would
produc
model
mild
diseas
subsequ
recoveri
later
time
point
describ
sarscov
context
interest
delet
merscov
phosphodiesteras
antagonist
rnase
l
activ
human
cell
appear
less
critic
elicit
sever
diseas
rodent
suggest
possibl
speciesspecif
mode
action
vivo
delet
sarscov
interferon
antagonist
gene
accessori
open
read
frame
also
yield
subtl
chang
overal
virul
vivo
howev
import
point
balanc
must
achiev
virul
mouseadapt
viru
enhanc
model
capac
replic
human
diseas
phenotyp
number
mutat
requir
significantli
reduc
dose
lethal
anim
test
convent
model
use
constitut
overexpress
merscov
receptor
demonstr
widespread
infect
extrapulmonari
tissu
includ
brain
kidney
liver
spleen
heart
two
studi
indic
mice
exhibit
multiorgan
failur
furthermor
high
viral
load
detect
brain
mice
transgen
overexpress
model
importantli
li
et
al
conclud
mortal
correl
brain
infect
suggest
infect
organ
import
high
mortal
observ
mice
lethal
model
valu
vaccin
immunotherapeut
test
smallmolecul
inhibitor
effect
lung
may
limit
efficaci
due
inabl
cross
bloodbrain
barrier
similar
neurolog
complic
observ
model
system
sar
use
overexpress
tissuespecif
constitut
promot
express
human
angiotensin
enzym
mice
addit
human
patholog
studi
need
determin
extent
extrapulmonari
site
merscov
replic
impact
merscov
diseas
clear
respiratori
replic
patholog
import
aspect
human
merscov
diseas
therefor
import
attribut
model
lack
detect
viru
replic
cn
mean
model
use
studi
merscovinduc
pulmonari
diseas
without
confound
effect
death
due
cn
infect
recent
debat
emerg
around
safeti
perform
gainoffunct
gof
studi
highli
pathogen
virus
merscov
sarscov
influenza
viru
http
wwwgryphonscientificcomgainoffunct
demonstr
gof
studi
absolut
necessari
develop
mous
model
reflect
ard
patholog
observ
previous
human
infect
respiratori
pathogen
importantli
gof
studi
perform
yield
merscov
strain
reflect
complex
clinic
isol
identifi
recent
human
delet
identifi
moreov
gof
studi
allow
us
identifi
mutat
merscov
protein
may
influenc
merscov
interact
possibl
circumv
host
immun
respons
nevertheless
futur
studi
evalu
host
factor
contribut
merscov
diseas
constrain
model
well
express
model
fact
mice
must
backcross
mous
line
harbour
modifi
endogen
gene
knockout
mice
limit
may
overcom
addit
gof
studi
facilit
merscov
adapt
innat
receptor
molecul
continu
threat
novel
emerg
pathogen
zika
viru
demand
rapid
develop
physiolog
relev
anim
model
evalu
therapeut
countermeasur
therebi
necessit
viru
adapt
host
immun
achiev
effect
model
critic
gof
regulatori
structur
imped
develop
robust
anim
model
human
diseas
essenti
protect
public
health
virus
cell
plaqu
assay
viru
stock
prepar
vero
cell
atcc
cell
maintain
routin
dulbecco
modifi
eagl
medium
gibco
supplement
fetal
bovin
serum
fb
sigma
antibioticantimycot
gibco
virus
harvest
optimem
medium
gibco
supplement
fb
antibioticantimycot
nonessenti
amino
acid
gibco
mm
sodium
pyruv
gibco
wildtyp
strain
merscov
use
passag
origin
provid
bart
haagman
erasmu
medic
center
rotterdam
netherland
passag
icmer
gener
previous
scobey
et
al
mer
camel
strain
dromedari
use
passag
provid
passag
malik
peiri
univers
hong
kong
china
gener
laboratori
rsb
describ
viru
titr
determin
plaqu
assay
vero
cell
virus
maintain
biosafeti
level
bsl
condit
redund
fan
personnel
power
airpurifi
respir
scrub
tyvek
suit
tyvek
apron
doubl
layer
glove
icmer
viru
tag
tomato
red
fluoresc
protein
passag
ten
round
cell
atcc
gener
stabli
overexpress
receptor
contain
express
cassett
use
gener
cell
line
describ
previous
sequenc
passag
viru
identifi
insert
three
amino
acid
rmr
amino
acid
spike
protein
chang
chang
subclon
back
merscov
infecti
clone
overlappcr
f
fragment
follow
primer
tagaatgcggcttgca
atagcacta
f
fragment
one
part
sevenplasmid
system
b
c
e
f
permit
partit
entir
genom
gener
infecti
merscov
describ
previous
pcr
product
encod
insert
subclon
back
f
fragment
use
restrict
enzym
msci
bamhi
valid
sequenc
recombin
viru
use
vivo
passag
experi
gof
studi
review
approv
nation
institut
health
nih
vero
cell
origin
receiv
atcc
indic
cell
line
authent
confirm
cell
line
mycoplasma
free
none
work
cell
line
stock
authent
test
mycoplasma
recent
although
origin
seed
stock
use
creat
work
stock
free
contamin
addit
cell
line
authent
morpholog
cytopatholog
evalu
furthermor
vero
cell
confirm
overexpress
capac
infect
replic
merscov
gener
mice
modifi
posit
exon
exon
allel
encod
amino
acid
shown
supplementari
fig
genom
engin
allel
genom
edit
system
perform
univers
north
carolina
chapel
hill
uncch
anim
model
core
facil
messeng
rna
mrna
encod
endonucleas
guid
rna
grna
base
system
establish
mali
et
al
prepar
describ
grna
supplementari
tabl
gener
vitro
transcript
reaction
use
high
yield
rna
synthesi
kit
neb
drailinear
templat
dna
use
reaction
follow
kit
guidelin
short
rna
transcript
reaction
incub
overnight
follow
dnase
rnasefre
digest
min
grna
purifi
use
rneasi
column
qiagen
follow
guidelin
short
rna
purif
cap
polyadenyl
mrna
prepar
vitro
transcript
reaction
use
mmessag
mmachin
ultra
kit
life
technolog
cap
mrna
gener
linear
plasmid
dna
reaction
contain
ntparca
solut
reaction
buffer
enzym
reaction
incub
h
follow
addit
turbo
dnase
digest
min
add
poli
tail
cap
mrna
reaction
mix
step
mix
nucleasefre
water
epap
buffer
mm
mncl
atp
solut
epap
final
reaction
volum
reaction
incub
min
cap
polyadenyl
rna
purifi
lithium
chlorid
precipit
resuspend
microinject
buffer
mm
trishcl
buffer
mm
edta
ph
fertil
zygot
collect
femal
superovul
mate
male
pronuclear
microinject
perform
ng
mrna
ng
grna
ng
grna
ng
donor
oligonucleotid
supplementari
tabl
inject
embryo
implant
pseudopregn
recipi
result
pup
screen
allel
encod
chang
supplementari
fig
posit
mutat
posit
detect
amplifi
biopsi
dna
sampl
follow
primer
bp
pcr
product
sequenc
primer
mutat
posit
detect
amplifi
biopsi
dna
sampl
follow
primer
bp
pcr
product
sequenc
primer
five
live
anim
produc
show
evid
modif
founder
expect
modif
backcross
mice
identifi
anim
modif
ci
f
anim
modif
intercross
produc
homozyg
breeder
pair
coloni
enrich
downstream
studi
mous
infect
genet
engin
mice
modifi
receptor
hous
bred
accord
guidelin
establish
depart
laboratori
anim
medicin
uncch
mice
novel
mous
line
develop
laboratori
rsb
experi
util
avail
male
femal
mice
rang
week
age
base
avail
time
experi
experiment
control
anim
ageand
sexmatch
blind
use
anim
experi
anim
random
sampl
size
determin
preliminari
data
would
yield
statist
signific
differ
mous
studi
execut
anim
condit
describ
previous
viral
infect
mice
anesthet
administ
ketaminexylazin
mixtur
intraperiton
infect
intranas
viru
solut
contain
pfu
incomplet
infect
due
bubbl
inoculum
nasal
caviti
inabl
inhal
entir
dose
inoculum
go
mouth
note
mice
consid
failur
exclud
describ
previous
follow
sedat
infect
mice
monitor
daili
weight
loss
surviv
well
sign
anim
moribund
includ
labour
breath
lack
movement
lack
groom
mice
reach
weight
loss
place
except
monitor
least
twice
daili
mice
approach
weight
loss
euthan
immedi
mice
deem
moribund
euthan
discret
research
mice
euthan
isofluran
overdos
follow
secondari
thoracotomi
variou
time
point
collect
lung
tissu
absenc
thoracotomi
cervic
disloc
use
secondari
euthanasia
method
approv
method
institut
anim
care
use
committe
iacuc
uncch
ethic
statement
mous
studi
carri
accord
recommend
care
use
anim
offic
laboratori
anim
welfar
nih
iacuc
uncch
approv
anim
studi
perform
protocol
iacuc
use
weight
loss
cutoff
point
human
euthanasia
synthet
reconstruct
merscov
approv
uncch
institut
biosafeti
committe
also
consid
gof
research
concern
execut
experi
analysi
serum
glucos
level
blood
glucos
measur
taken
follow
h
fast
blood
glucos
measur
tail
clip
sampl
use
alphatrak
glucomet
abbott
laboratori
system
design
use
laboratori
mice
normal
rang
mg
dl
mmol
l
blood
glucos
detect
limit
mg
dl
mmol
l
blood
glucos
human
monoclon
antibodi
protect
studi
mice
prophylact
administ
human
monoclon
antibodi
isotyp
control
antibodi
intraperiton
inject
h
infect
mice
monitor
daili
weight
surviv
kill
day
pi
collect
lung
histolog
viral
titr
assess
plaqu
assay
evalu
lung
haemorrhag
respiratori
function
measur
day
establish
baselin
day
pi
isol
product
antibodi
describ
previous
spikevrp
vaccin
studi
viru
neutral
assay
merscov
gene
encod
spike
protein
gfp
gene
packag
vrp
gener
helper
construct
attenu
strain
venezuelan
equin
enceph
viru
condit
describ
previous
mice
administ
primari
vaccin
footpad
inject
spikevrp
pfu
control
gfpvrp
pfu
day
mice
boost
dose
respect
vrp
strain
day
postboost
vaccin
mice
challeng
pfu
mice
monitor
daili
weight
surviv
kill
day
pi
collect
lung
histolog
assess
viral
titr
plaqu
assay
evalu
lung
haemorrhag
respiratori
function
measur
day
establish
baselin
day
pi
presenc
serum
antibodi
assess
plaqu
reduct
neutral
titr
assay
prechalleng
serum
sampl
collect
day
postboost
spikevrp
vaccin
gfpvrp
control
viru
neutral
assay
perform
describ
previous
percentag
plaqu
reduct
calcul
number
plaqu
spikevrp
gfpvrp
serumnumb
plaqu
serum
mice
respiratori
function
respiratori
function
measur
individu
mice
indic
time
point
demonstr
previous
sarscov
influenza
viru
briefli
individu
mice
acclim
min
individu
plethysmographi
chamber
buxco
system
breath
quantifi
min
period
mice
routin
random
differ
chamber
avoid
measur
bias
could
result
chamber
data
penh
ef
analys
describ
previous
group
histolog
lung
brain
kidney
sampl
place
phosphatebuff
formalin
day
fixat
fix
tissu
sampl
remov
place
cassett
embed
paraffin
submit
lineberg
comprehens
cancer
center
anim
histopatholog
core
process
section
stain
tissu
section
stain
haematoxylin
eosin
merscov
nucleocapsid
antigen
detect
use
mous
antim
nucleocapsid
serum
dilut
nucleocapsid
antiserum
gener
laboratori
rsb
use
merscov
nucleocapsidvrp
particl
balbc
mice
describ
previous
antigen
visual
use
stain
olympu
camera
attach
olympu
microscop
use
captur
imag
object
histopatholog
score
blind
infect
anim
statu
airway
diseas
vascular
diseas
parenchym
pneumonia
diffus
alveolar
damag
eosinophil
immunohistochemistri
scale
none
mild
moder
sever
flow
cytometri
analysi
whole
peripher
blood
mous
strain
collect
edta
peripher
blood
mononuclear
cell
purifi
use
densitygradi
centrifug
ficollpaqu
plu
ge
healthcar
life
scienc
mous
lung
tissu
first
dissoci
mechan
use
scalpel
blade
digest
use
type
collagenas
worthington
biochem
medium
prepar
dnase
mg
ml
h
shake
incub
digest
lung
suspens
filter
centrifug
treat
ack
lysi
buffer
gibco
singlecel
suspens
blood
lung
tissu
resuspend
cell
ml
rpmi
medium
supplement
heatinactiv
fb
antibioticantimycot
cocktail
gibco
use
immedi
flow
cytometri
singlecel
suspens
plate
per
well
roundbottom
plate
stain
flow
cytometri
use
intracellular
fixat
permeabil
buffer
set
ebiosci
accord
manufactur
protocol
use
antibodi
specif
clone
bd
bioscienc
clone
bd
bioscienc
clone
ebiosci
clone
bd
bioscienc
clone
biolegend
clone
ebiosci
clone
bd
bioscienc
tumournecrosi
clone
ebiosci
clone
ebiosci
cell
also
treat
fixabl
livedead
discrimin
invitrogen
stain
cell
fix
min
paraformaldehyd
resuspend
pb
store
acquisit
within
h
cell
popul
first
gate
exclud
debri
doublet
event
dead
cell
phenotyp
function
gate
sampl
stain
parallel
control
fluoresc
minimum
live
singlet
event
acquir
per
sampl
data
analys
use
flowjo
softwar
treestar
northern
blot
analysi
rtpcr
northern
blot
analysi
perform
detect
fulllength
lung
wildtyp
mice
poli
rna
isol
elimin
ribosom
rna
rrna
qiagen
equival
amount
rna
resolv
agaros
gel
transfer
nitrocellulos
membran
biotinyl
probe
biotindt
use
detect
quantifi
viral
target
host
mrna
merscov
mous
glyceraldehyd
dehydrogenas
gapdh
rna
measur
brain
lung
tissu
merscovinfect
mice
briefli
tissu
remov
place
rnalat
ambion
solut
store
analysi
rtpcr
lung
tissu
homogen
trizol
reagent
invitrogen
isol
accord
manufactur
instruct
standard
rtpcr
perform
follow
primer
pair
indic
rna
merscov
subgenom
leader
sequenc
mous
gapdh
equival
volum
pcr
product
resolv
gel
nonquantit
answer
presenc
absenc
viral
subgenom
transcript
brain
lung
quantit
rtpcr
carri
roch
lightcycl
ii
accompani
softwar
analys
merscov
viral
rna
mrna
rrna
endogen
control
rna
revers
transcrib
standard
condit
reaction
volum
use
superscript
iii
revers
transcriptas
invitrogen
merscov
viral
rna
assess
use
follow
primer
nm
reaction
sybr
green
assay
ssoadvanc
univers
sybr
green
supermix
biorad
forward
primer
anneal
merscov
leader
sequenc
untransl
region
revers
primer
anneal
n
gene
pcr
condit
cycl
standard
taqman
condit
use
analys
express
rrna
follow
primer
use
probe
use
roch
univers
probelibrari
pcr
condit
cycl
commerci
avail
primerprob
set
util
quantit
rrna
life
technolog
statist
analysi
quantit
data
present
mean
sd
signific
specif
data
set
describ
respect
figur
legend
determin
student
ttest
use
onetail
twotail
distribut
microsoft
excel
softwar
biosafeti
biosecur
vivo
adapt
viru
mice
execut
public
us
govern
statement
fund
paus
certain
type
gof
research
notic
ceas
vivo
passag
experi
receiv
studi
adapt
viru
vivo
immedi
halt
follow
formal
written
request
continu
receiv
exempt
paus
approv
continu
nation
institut
allergi
infecti
diseasesnih
review
vivo
adapt
continu
serial
passag
mice
studi
use
merscov
execut
facil
uncch
condit
describ
previous
follow
biosafeti
biosecur
paragraph
describ
menacheri
et
al
work
studi
perform
approv
standard
oper
procedur
safeti
condit
merscov
select
agent
sarscov
select
agent
deriv
therein
institut
cov
facil
design
conform
safeti
requir
recommend
biosafeti
microbiolog
biomed
laboratori
us
depart
health
human
servic
public
health
servic
center
diseas
control
nih
laboratori
safeti
plan
submit
facil
approv
use
unc
depart
environment
health
safeti
eh
cdc
electron
card
access
requir
entri
facil
worker
train
eh
safe
use
power
airpurifi
respir
appropri
work
habit
facil
activ
medic
surveil
plan
place
facil
contain
redund
fan
emerg
power
fan
biolog
safeti
cabinet
freezer
facil
accommod
sealsaf
mous
rack
materi
classifi
agent
consist
merscov
sarscov
bat
cov
precursor
strain
mutant
deriv
pathogen
within
facil
experiment
infecti
viru
perform
certifi
class
ii
biosafeti
cabinet
member
staff
wear
scrub
tyvek
suit
apron
power
airpurifi
respir
shoe
cover
hand
doubleglov
user
subject
medic
surveil
plan
monitor
univers
employe
occup
health
clinic
ueohc
includ
yearli
physic
annual
influenza
vaccin
mandatori
report
symptom
associ
coronviru
infect
period
work
user
train
exposur
manag
report
protocol
prepar
selfquarantin
train
safe
deliveri
local
infecti
diseas
manag
depart
emerg
situat
potenti
exposur
event
report
investig
eh
ueohc
report
file
cdc
nih
data
avail
data
support
find
studi
avail
correspond
author
request
